Nemoto: perfecting image technology for better medical diagnosis
The leading developer of high-precision contrast injectors for CT, MRI and Angiography, Nemoto works with medical professionals and leading organizations to develop, improve and find new uses for its products.
Monozukuri – the Japanese manufacturing philosophy centered around craftsmanship, innovation and pursuit of the highest quality – lends itself greatly to the creation of high-precision equipment for the medical device industry.
For this reason, many medical professionals depend on the expertise and technological know-how of Japanese medical device manufacturers like Nemoto, whose highprecision contrast injectors for CT, MRI and Angiography are used in medical facilities in Japan, the US, Europe and throughout the world.
Having introduced the first cerebral angiography contrast injector in Japan, Nemoto continues to pursue pioneering innovation, working
“Our long-term goal is to continuously drive towards creating the perfect image”
Shigeru Nemoto, President, Nemoto Kyorindo Co., Ltd.
in collaboration with both physicians and leading global medical organizations to develop, improve and find new uses for its products.
“As the birthplace of monozukuri, Japan is the ideal place to produce medical devices. With each medical device, we like to try to understand how far monozukuri can work in the production of that device,” says company president, Shigeru Nemoto. “Monozukuri is a philosophy that guides us to where we and our products are headed.”
Nemoto’s success has been firmly rooted in its willingness to work closely with radiologists and physicians to acutely understand their needs in order to develop the most appropriate equipment to meet those needs. Such research and development – based on a high-degree of first-hand knowledge of the situations in which its products are used – is what sets Nemoto apart from many of its competitors, and why many medical professionals choose Nemoto’s contrast injector solutions over others available on the market.
“Medical facilities are the true battlefield for our products, so collaborating with those on the ground gives us the most authentic feedback,” says Mr. Nemoto. Even though we are small compared to our competition, we have observed larger companies failing at a task in which we have succeeded, because we have kept to our strategy of speaking with physicians first. This gives us a huge advantage.”
Nemoto’s latest innovations
As the company looks to expand its presence on the international market, it will continue its strategy of “speaking with physicians first” to ensure its goal of developing products that are exactly aligned with the needs of medical professionals. One of the key issues for Nemoto focuses on how to make injectors lighter and easier to use while maximizing efficacy, which led to the development of its latest angiographic injectors, like the PRESS DUO elite. “For this new product, it’s the first and only technology of its kind in the USA, and we are now expanding it into Europe. This new product encompasses our strategies, making it aligned with the users,” adds Mr. Nemoto.
Thanks to its successful collaboration with medical professionals and leading organizations, Nemoto continues to pioneer medical device innovations and is currently working on an injector for heart catheterization, which marks a major milestone for the company.
Meanwhile, its R&D department, in collaboration with leading Japanese universities, has also put focus on developing new uses for its injector technology, such as in the delivery of anti-cancer drugs, while Nemoto’s long-term goal remains “to continuously drive towards creating the perfect image”.
“We continuously work with key leaders, such as Dr. Jean-Louis Sablayrolles and Dr. Laurent Macron at Centre Cardiologique du Nord – who are using the latest CT technology from GE Healthcare – and with leading partners like Siemens Healthineers, to understand how we can improve our products to maximize all the technological elements of the imaging process to achieve as near perfect an image as possible,” explains Mr. Nemoto.
“We are planning to be the pioneer once again with our newest angiography injector through our partnership with Siemens Healthineers in the USA.”